Clinical Trial Update: Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 trial evaluating post-transplant use of inotuzumab ozogamicin for acute lymphoblastic leukemia; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Besponsa (inotuzumab ozogamicin)

Snippet

Sponsor: Leland Metheny | Conditions: Acute Lymphocytic Leukemia | Phase 1, Phase 2 | Status: RECRUITING